2KTD

Solution structure of mouse lipocalin-type prostaglandin D synthase / substrate analog (U-46619) complex

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	1.0mM [U-15N] protein; 1.5mM 15-hydroxy-11alpha,9alpha-(epoxymethano)prosta-5,13-dienoic acid; 90% H2O/10% D2O	90% H2O/10% D2O		7.0	1 atm	300.5
2	3D HNCACB	1.0mM [U-13C; U-15N] protein; 1.5mM 15-hydroxy-11alpha,9alpha-(epoxymethano)prosta-5,13-dienoic acid; 90% H2O/10% D2O	90% H2O/10% D2O		7.0	1 atm	300.5
3	3D CBCA(CO)NH	1.0mM [U-13C; U-15N] protein; 1.5mM 15-hydroxy-11alpha,9alpha-(epoxymethano)prosta-5,13-dienoic acid; 90% H2O/10% D2O	90% H2O/10% D2O		7.0	1 atm	300.5
4	3D HCCH-TOCSY	1.0mM [U-13C; U-15N] protein; 1.5mM 15-hydroxy-11alpha,9alpha-(epoxymethano)prosta-5,13-dienoic acid; 90% H2O/10% D2O	90% H2O/10% D2O		7.0	1 atm	300.5
5	3D 1H-15N NOESY	1.0mM [U-15N] protein; 1.5mM 15-hydroxy-11alpha,9alpha-(epoxymethano)prosta-5,13-dienoic acid; 90% H2O/10% D2O	90% H2O/10% D2O		7.0	1 atm	300.5
6	3D 1H-13C NOESY	1.0mM [U-13C; U-15N] protein; 1.5mM 15-hydroxy-11alpha,9alpha-(epoxymethano)prosta-5,13-dienoic acid; 90% H2O/10% D2O	90% H2O/10% D2O		7.0	1 atm	300.5
7	3D HBHA(CO)NH	1.0mM [U-13C; U-15N] protein; 1.5mM 15-hydroxy-11alpha,9alpha-(epoxymethano)prosta-5,13-dienoic acid; 90% H2O/10% D2O	90% H2O/10% D2O		7.0	1 atm	300.5

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	INOVA	600

NMR Refinement
Method	Details	Software
simulated annealing		NMRView

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	1500
Conformers Submitted Total Number	15
Representative Model	1 (closest to the average)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	chemical shift assignment	NMRView		Johnson, One Moon Scientific
2	geometry optimization	CNS		Brunger, Adams, Clore, Gros, Nilges and Read
3	refinement	CNS

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.